Hisham Shiblaq - Feb 16, 2023 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
EVP, Chief Comm. Officer
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Hisham Shiblaq
Stock symbol
PRCT
Transactions as of
Feb 16, 2023
Transactions value $
$0
Form type
4
Date filed
2/21/2023, 03:33 PM
Previous filing
Jan 5, 2023
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Award $0 +26.3K +96.48% $0.00 53.6K Feb 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Award $0 +47.7K $0.00 47.7K Feb 16, 2023 Common Stock 47.7K $37.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2023, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.
F2 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2023 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.